[go: up one dir, main page]

WO2000012461A1 - Process for making 2-amino-5-cyanophenol - Google Patents

Process for making 2-amino-5-cyanophenol Download PDF

Info

Publication number
WO2000012461A1
WO2000012461A1 PCT/US1999/019494 US9919494W WO0012461A1 WO 2000012461 A1 WO2000012461 A1 WO 2000012461A1 US 9919494 W US9919494 W US 9919494W WO 0012461 A1 WO0012461 A1 WO 0012461A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
compound
iii
aprotic solvent
cyanide
Prior art date
Application number
PCT/US1999/019494
Other languages
French (fr)
Inventor
Clifford S. Labaw
Susan C. Shilcrat
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Priority to CA002341711A priority Critical patent/CA2341711A1/en
Priority to JP2000567496A priority patent/JP2003525856A/en
Priority to EP99943937A priority patent/EP1107943A4/en
Publication of WO2000012461A1 publication Critical patent/WO2000012461A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/06Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/14Preparation of carboxylic acid nitriles by reaction of cyanides with halogen-containing compounds with replacement of halogen atoms by cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups

Definitions

  • PROCESS FOR MAKING 2-AMINO-5-CYANOPHENOL Scope of the Invention This invention relates to a process for making intermediates useful for making certain phenyl urea compounds.
  • the end-product phenyl urea compounds are useful in treating IL-8, GRO ⁇ , GRO ⁇ , GRO ⁇ and NAP-2 mediated diseases. They are disclosed in PCT application serial number PCT/US96/13632, published 21 August 1997 as WIPO No. WO97/29743 and co-pending U.S. application 08/894291.
  • Interleukin-8 is a chemoattractant for neutrophils, basophils, and a subset of
  • T-cells The T-cells. It is produced by a majority of nucleated cells including macrophages, fibroblasts, endothelial and epithelial cells exposed to TNF, IL-la, IL-lb or LPS, and by neutrophils themselves when exposed to LPS or chemotactic factors such as FMLP.
  • This invention provides a method for making 2-amino-5-cyano-phenol which is a useful intermediate for synthesising N-[2-hydroxy-4-cyanophenyl]-N'-[2-bromophenyl]urea, a compound disclosed in the aforementioned PCT application.
  • This invention relates to a process for making 2-amino-5-cyanophenol.
  • this process comprises preparing the phenol of Formula (I)
  • this invention comprises a process for preparing a compound of Formula (I) from o-anisidine, which process comprises treating o-anisidine with a halogenating agent to obtain Formula (III)
  • Scheme 1 outlines the chemistry for preparing to 2-amino-5-cyanophenol, a third stage intermediate in a synthesis of N-[2-hydroxy-4-cyanophenyl]-N'-[2- bromophenyljurea.
  • stage A The p ⁇ r ⁇ bromination of o-anisidine (stage A) has been described in the literature, using several different reagents (Choudary, B. M.; Sudha, Y., and Reddy, P. N. Synlett., 1994, 450; Reeves, W. P.; and King, R. M. Synth. Comm. 1993, 23, 855; Fox, G. J.; Hallas, G.; Hepworth, J. D.; and Paskins, K. N. Org. Synth., Coll. Vol. 6, 181).
  • the crude reaction product is typically a mixture of the starting material, Formula (III), the ortho isomer 2-bromo-6-methoxy-aniline (1) and the product of over bromination, 2,4-dibromo-6-methoxy-aniline (2) below.
  • a typical crude GC product ratio for 2,4,4,6-tetrabromo-2,5-cyclohexadien-l-one was 15% o- anisidine/6% formula 1/61% o-anisidine/17% formula 2; for HBr-DMSO it was 13% o-anisidine/13% formula 1/53% Formula (II)/22% formula 2.
  • stage b was effected by treating Formula (III) with copper (I) cyanide in either refluxing NN-dimethylformamide or l-methyl-2-pyrrolidinone for 3-5 hours. While the reaction proceeded faster in l-methyl-2-pyrrolidinone, workup was difficult and it was easiest to carry the crude reaction mixture through stage c, then purify by crystallization Stage c provided a crude recovery of 75%.
  • stage c Demethylation of crude Formula (II) (stage c) was effected by several reagents: boron tribromide, sodium ethyl thiolate, and sodium cyanide in refluxing dimethyl sulfoxide.
  • boron tribromide the reaction is carried out in an aprotic solvent such as methylene chloride.
  • the reaction is carried out under an inert gas such as nitrogen. This reaction goes to completion at a reduced temperature, i.e., about -10 to +10 °C in about 1-3 hours.
  • the sodium cyanide reaction proceeds best in dimethyl sulfoxide.
  • the reaction is run under an inert gas such as nitrogen. Refluxing for 3-7 hours is needed to effect the reaction.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

This invention relates to a process for preparing 2-amino-5-cyanophenol.

Description

PROCESS FOR MAKING 2-AMINO-5-CYANOPHENOL Scope of the Invention This invention relates to a process for making intermediates useful for making certain phenyl urea compounds. The end-product phenyl urea compounds are useful in treating IL-8, GROα, GROβ, GROγ and NAP-2 mediated diseases. They are disclosed in PCT application serial number PCT/US96/13632, published 21 August 1997 as WIPO No. WO97/29743 and co-pending U.S. application 08/894291.
Area of the Invention Interleukin-8 is a chemoattractant for neutrophils, basophils, and a subset of
T-cells. It is produced by a majority of nucleated cells including macrophages, fibroblasts, endothelial and epithelial cells exposed to TNF, IL-la, IL-lb or LPS, and by neutrophils themselves when exposed to LPS or chemotactic factors such as FMLP. M. Baggiolini et al, J. Clin. Invest. 84, 1045 (1989); J. Schroder et al, J. Immunol. 139, 3474 (1987) and J. Immunol. 144, 2223 (1990) ; Strieter, et al,
Science 243, 1467 (1989) and /. Biol Chem. 264, 10621 (1989); Cassatella et al, J. Immunol. 148, 3216 (1992).
There is a need for treatment in this field, for compounds, which are capable of binding to the IL-8 α or β receptor. Therefore, conditions associated with an increase in IL-8 production (which is responsible for chemotaxis of neutrophil and T-cells subsets into the inflammatory site) would benefit by compounds, which are inhibitors of IL-8 receptor binding. Such compounds have been disclosed in published patent applications exemplified by the likes of PCT/US96/13632, published 21 August 1997 as WIPO No. WO97/29743. This invention provides a method for making 2-amino-5-cyano-phenol which is a useful intermediate for synthesising N-[2-hydroxy-4-cyanophenyl]-N'-[2-bromophenyl]urea, a compound disclosed in the aforementioned PCT application.
SUMMARY OF THE INVENTION This invention relates to a process for making 2-amino-5-cyanophenol. In particular, this process comprises preparing the phenol of Formula (I)
Figure imgf000004_0001
by demythelating a compound of Formula (II).
Figure imgf000004_0002
In addition, this invention comprises a process for preparing a compound of Formula (I) from o-anisidine, which process comprises treating o-anisidine with a halogenating agent to obtain Formula (III)
Figure imgf000004_0003
and displacing the bromide by a cyanide anion to obtain a compound of Formula (II) then demethylating Formula (II) to obtain the compound of Formula
(I).
Description of the Invention
Scheme 1 outlines the chemistry for preparing to 2-amino-5-cyanophenol, a third stage intermediate in a synthesis of N-[2-hydroxy-4-cyanophenyl]-N'-[2- bromophenyljurea. Scheme I
OMe stage a stage c_
Figure imgf000005_0001
Figure imgf000005_0003
Figure imgf000005_0002
(HI) (ID (I)
The pαrα bromination of o-anisidine (stage A) has been described in the literature, using several different reagents (Choudary, B. M.; Sudha, Y., and Reddy, P. N. Synlett., 1994, 450; Reeves, W. P.; and King, R. M. Synth. Comm. 1993, 23, 855; Fox, G. J.; Hallas, G.; Hepworth, J. D.; and Paskins, K. N. Org. Synth., Coll. Vol. 6, 181). The crude reaction product is typically a mixture of the starting material, Formula (III), the ortho isomer 2-bromo-6-methoxy-aniline (1) and the product of over bromination, 2,4-dibromo-6-methoxy-aniline (2) below.
Figure imgf000005_0004
1 2
The following reagents gave Formula (III) as the principle product in the reaction mixture: 2,4,4,6-tetrabromo-2,5-cyclohexadien-l-one, hexamethylenetetramine hydrobromide perbromide, benzyltrimethylammonium tribromide, tetrabutylammonium tribomide, pyridinium bromide perbromide, ammonium molybdate-potassium bromide-hydrogen peroxide-acetic acid, sodium tungstate-potassium bromide-hydrogen peroxide-acetic acid, and 48% hydrobromic acid in warm (60-80 °C) dimethyl sulfoxide. The preferred results were achieved with 2,4,4,6-tetrabromo-2,5-cyclohexadien-l-one and 48% hydrobromic acid in dimethyl sulfoxide. While 2,4,4,6-tetrabromo-2,5-cyclohexadien-l-one gave somewhat better isomer ratios, hydrobromic acid in dimethyl sulfoxide had the advantage of requiring no unusual reagent, only ordinary bulk chemicals. A typical crude GC product ratio for 2,4,4,6-tetrabromo-2,5-cyclohexadien-l-one was 15% o- anisidine/6% formula 1/61% o-anisidine/17% formula 2; for HBr-DMSO it was 13% o-anisidine/13% formula 1/53% Formula (II)/22% formula 2.
It was possible to isolate and purify Formula (III) through its sulfate salt. An ethyl acetate solution of the crude reaction mixture was treated with an ethyl acetate solution of concentrated sulfuric acid. The sulfate salt of Formula (II) crystallized from solution in enhanced purity. Recrystallization of Formula (II) from an alcohol solvent gave material of high chemical and isomeric purity. The free base was regenerated by standard aqueous extractive methodology.
Using HBr-DMSO as the brominating agent, and purifying via the sulfate salt, 100 g o-anisidine was transformed to 46 g or Formula (III).
Cyanation, (stage b) was effected by treating Formula (III) with copper (I) cyanide in either refluxing NN-dimethylformamide or l-methyl-2-pyrrolidinone for 3-5 hours. While the reaction proceeded faster in l-methyl-2-pyrrolidinone, workup was difficult and it was easiest to carry the crude reaction mixture through stage c, then purify by crystallization Stage c provided a crude recovery of 75%.
Demethylation of crude Formula (II) (stage c) was effected by several reagents: boron tribromide, sodium ethyl thiolate, and sodium cyanide in refluxing dimethyl sulfoxide. Where boron tribromide is used, the reaction is carried out in an aprotic solvent such as methylene chloride. Preferably the reaction is carried out under an inert gas such as nitrogen. This reaction goes to completion at a reduced temperature, i.e., about -10 to +10 °C in about 1-3 hours. The sodium cyanide reaction proceeds best in dimethyl sulfoxide. The reaction is run under an inert gas such as nitrogen. Refluxing for 3-7 hours is needed to effect the reaction. If sodium ethyl thiolate is used, dimethyl formamide is the solvent of choice. Again the reaction is carried out under an inert gas, nitrogen for example. Mildy elevated temperatures are needed to run the reaction; 75 to 125 °C for 30 minutes to 2 hours or so should cause the reaction to go to completion. An experimental procedure for each stage of the reaction set out in Scheme I is detailed below.
Examples Example 1 2-Methoxy-4-Bromo-Aniline
A stirred solution of o-anisidine; (104.6 g; 0.85 mol; Aldrich) in dry DMSO (1000 mL) under nitrogen, was treated with 48% HBr (185 mL; 1.64 mol; 1.9 eq; Aldrich) over 10-12 min. The reaction mixture spontaneously exothermed to -50 °C. After addition was complete, the reaction was heated to 80 °C and maintained at that temperature for 20 min. The reaction mixture was cooled to 5 °C, then partitioned between EtOAc (2L) and 1.5 N NaOH (2.4 L). After separating the phases, the aqueous layer was washed with additional EtOAc (1 L). The combined EtOAc layers were washed with H2O (2 x 2 L) and saturated brine (1 L), dried over magnesium sulfate (100 g), filtered, and concentrated in vacuo to a dark oil (163.9 g).
The crude product mixture was redissolved in EtOAc (1 L) and transfered to a stirred 2 L vessel. A solution of 18 N sulfuric acid (100 mL; 1.8 mol) in EtOAc (400 mL) was added in one portion. The EtOAc solution spontaneously exothermed to -50 °C. (If necessary to dissolve all solids, the reaction mixture was heated to reflux.) The mixture was allowed to cool slowly to ambient temperature. The resultant white crystals were collected by filtration, washed with EtOAc (100 mL) and dried to give 120.8 g Formula(III)-sulfate salt. This was recrystallized from 2- propanol (900 mL). The resultant crystals were filtered, washed with cold 2- propanol (100 mL), and force-air dried (58.7 g). To liberate the free base, the crystalline sulfate salt was partitioned between 1
N NaOH (1 L) and EtOAc (1 L). The mixture was stirred until all solids disappeared, then the phases were separated. The aqueous phase was washed with additional EtOAc (500 mL). The combined EtOAc phases were washed with H2O (1 L) and saturated brine (500 mL), then dried over magnesium sulfate (50 g). The solution was filtered, and concentrated in vacuo to produce Forumla (III) as a white solid (46.25 g; 27% yield), mp 56-58 °C. lU NMR (DMSO-d6) δ 3.75 (s, 3H), 4.86 (b, 2H), 6.55 (d, J = 8.3 Hz, IH), 6.80 (dd, J = 8.3, 2.2 Hz, IH), 6.89 (d, J = 2.2 Hz, IH). 13C NMR (DMSO-d6) δ 147.1, 137.2, 123.2, 114.7, 113.4, 106.2, 55.6.
Example 2 2-Methoxy-4-Cyano- Aniline A solution of 2-methoxy-4-bromoaniline (8.66 g; 42.9 mmol) in N,N- dimethylformamide (100 mL) under nitrogen was treated with copper (I) cyanide (5.75 g; 64.3 mmol; 1.5 eq). The reaction mixture was refluxed 5-6 h. After cooling, 10% aq FeCl3 (100 mL) and EtOAc (100 mL) were added. Stirring was continued 10 min, followed by filtration through Celite. The aqueous phase was washed with additional EtOAc (50 mL). The combined organic phases were washed with H2O (100 mL) and saturated brine (50 mL), and dried over magnesium sulfate (2.5 g). Upon concentration in vacuo, the captioned compound was isolated as a crude oil and used without further purification. lU NMR (CDC13) δ 3.76 (s, 3H), 4.75 (b), 6.57 (d, J = 8.1 Hz, IH), 6.86 (d, 7 = 1.7 Hz, IH), 7.04 (dd, 7 = 8.1, 1.7 Hz, 1H);13C NMR (CDC13) δ 146.1, 141.1, 126.6, 120.3, 113.5, 112.8, 99.2, 55.6.
Example 3 2-Amino-5-Cyano-PhenoI2-Methoxy-4-cyanoaniline was demethylated to form 2-amino-5-cyano-phenol by several reagents (a-c).
3a - Boron Tribromide: A solution of crude 2-methoxy-4-cyanoaniline (1.78 g; 12 mmol) in methylene chloride (25 mL) under nitrogen was cooled to 0 °C. A 1 M solution of boron tribromide in methylene chloride (24 mL; 24 mmol; 2 eq; Aldrich) was added dropwise over 20 min; the temperature was maintained below 5 °C. Stirring continued 2 hours at 0 °C. 5% aq NaHCO3 (100 mL)was added, followed by extraction with EtOAc (2 x 50 mL). The organic phases were washed with H2O (50 mL) and sat brine (50 mL) and dried over magnesium sulfate (4 g). The solution was filtered and concentrated in vacuo. The residue was stirred with methylene chloride (10 mL) to give the captioned compound as a solid (0.57 g; 35% yield) emerged from solution, mp 128-130 °C (d); lH NMR (DMSO-d6) δ 5.74 (s, IH), 6.62 6.63 (d, J = 8.1 Hz, IH), 6.85 (d, I = 1.8 Hz, IH), 6.98 (dd, J = 8.1, 1.8 Hz, IH), 9.78 (b, 2H); 13C NMR (DMSO-d6) δ 143.4, 142.5, 125.3, 120.7, 116.2, 113.3, 95.8.
3b - Sodium Cyanide in DMSO: Under nitrogen, a solution of crude 2- methoxy-4-cyanoaniline (0.41 g; 2.77 mmol) in dry DMSO (4 mL) was treated with solid sodium cyanide (0.68 g; 13.85 mmol; 5 eq) and heated to reflux for 5 hours. The cooled mixture was partitioned between H2O (20 mL) and EtOAc (20 mL). The pH of the aqueous phase was adjusted to 7 with 1 N HC1, and the phases were separated. The organic phase was washed with H2O (10 mL) and sat. brine (10 mL), and dried over magnesium sulfate (2 g). Concentration in vacuo gave the title compound as a tan solid (240 mg; 65% yield).
3c - Sodium Ethyl Thiolate in DMF: Under nitrogen, a solution of crude 2- methoxy-4-cyanoaniline (0.33 g; 2.23 mmol) in DMF (4 mL) was treated with a solution of sodium ethyl thiolate (0.29 g; 3.45 mmol; 1.55 eq; Aldrich) in DMF (1 mL). The reaction mixture was heated to 100 °C for 1 hour. The mixture was cooled and partitioned between saturated NH4C1 soln(10 mL) and EtOAc (10 mL). The pH of the aqueous phase was adjusted to 5 with 1 N HC1, and the phases were separated. The organic phase was washed with H2O (10 mL), saturated brine (10 mL), and dried over magnesium sulfate (1 g). Concentration in vacuo gave the title compound as a tan solid (230 mg; 77% yield).

Claims

What is claimed is:
1. A process for preparing a compound of Formula (I),
Figure imgf000010_0001
which process comprises demythelating a compound of Formula (II).
Figure imgf000010_0002
2. The process of claim 1 wherein the demethylation is carried out using boron tribromide in an aprotic solvent, sodium cyanide in dimethyl sulfoxide, or sodium ethyl thiolate in dimethyl formamide.
3. The process of claim 2 wherein the demethylation is carried out using boron tribromide in an aprotic solvent under an inert gas at temperatures between - 10 and +10 °C for about 1-3 hours.
4. The process of claim 2 wherein the demethylation is carried out using sodium cyanide in an aprotic solvent under an inert gas at reflux for about 3-7 hours.
5. The process of claim 2 wherein the demethylation is carried out using sodium ethyl thiolate in an aprotic solvent under an inert gas and heating the solution to about 75 to 125 °C for about 30 minutes to 2 hours.
6. A process for preparing a compound of Formula (I)
Figure imgf000011_0001
from o-anisidine, which process comprises treating o-anisidine with a halogenating agent to obtain Formula (III)
NH,
O
halo (III)
where halo is any halogen and displacing the halogen by a cyanide anion to obtain a compound of Formula (II)
Figure imgf000011_0002
and, demethylated Formula (II) to obtain the compound of Formula (I).
7. A process for making a compound of Formula (III)
Figure imgf000011_0003
where halo is any halogen which process comprises treating a compound of Formula A
Figure imgf000012_0001
with a halogenating agent in dimethylsulfoxide.
8. A process for preparing a compound of Formula (II)
Figure imgf000012_0002
which process comprises treating a compound of Formula (III)
Figure imgf000012_0003
with copper (I) cyanide in an aprotic solvent.
PCT/US1999/019494 1998-08-28 1999-08-26 Process for making 2-amino-5-cyanophenol WO2000012461A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002341711A CA2341711A1 (en) 1998-08-28 1999-08-26 Process for making 2-amino-5-cyanophenol
JP2000567496A JP2003525856A (en) 1998-08-28 1999-08-26 Method for producing 2-amino-5-cyanophenol
EP99943937A EP1107943A4 (en) 1998-08-28 1999-08-26 Process for making 2-amino-5-cyanophenol

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9833598P 1998-08-28 1998-08-28
US60/098,335 1998-08-28

Publications (1)

Publication Number Publication Date
WO2000012461A1 true WO2000012461A1 (en) 2000-03-09

Family

ID=22268831

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/019494 WO2000012461A1 (en) 1998-08-28 1999-08-26 Process for making 2-amino-5-cyanophenol

Country Status (4)

Country Link
EP (1) EP1107943A4 (en)
JP (1) JP2003525856A (en)
CA (1) CA2341711A1 (en)
WO (1) WO2000012461A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709485B2 (en) 2002-10-29 2010-05-04 Glaxosmithkline Llc IL-8 receptor antagonists
US7893089B2 (en) 2006-04-21 2011-02-22 GlaxoSmithKline, LLC IL-8 receptor antagonists
US8097626B2 (en) 2006-04-21 2012-01-17 Glaxosmithkline Llc IL-8 receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1792156A (en) * 1928-01-17 1931-02-10 Gen Aniline Works Inc 5-halogen-2-amino-1-alkyloxy and 1-aralkyloxy-benzenes and intermediate products thereof and process of preparing them
EP0100172B1 (en) * 1982-07-23 1987-08-12 Imperial Chemical Industries Plc Amide derivatives
CH679150A5 (en) * 1986-11-07 1991-12-31 Oreal
AU6250298A (en) * 1997-01-30 1998-08-25 American Home Products Corporation Substituted hydroxy-anilino derivatives of cyclobutene-3,4-diones

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BENTON ET AL.: "The Cleavage of Ethers with Boron Bromide. I. Some Common Ethers", J. AMER. CHEM. SOC., vol. 64, May 1942 (1942-05-01), pages 1128 - 1129, XP002925614 *
CALLEN ET AL.: "9-CYANOPHENANTHRENE", ORGANIC SYNTHESES COLLECTIVE, vol. 3, 1955, pages 212 - 213, XP002925621 *
FRASER ET AL.: "Demethylation of Labile Aryl Ethers", J. ORG. CHEM., vol. 41, no. 1, 1976, pages 170 - 171, XP002925615 *
NEWMAN ET AL.: "Phenolic and Ketonic Tautomers in Polycyclic Aromatic Hydrocarbons", J. AMER. CHEM. SOC., vol. 98, no. 11, 26 May 1976 (1976-05-26), pages 3237 - 3242, XP002925616 *
NEWMAN M.S.: "alpha-Napthonitrile", ORG. SYN. COL., vol. 3, 1955, pages 631 - 633, XP002925617 *
See also references of EP1107943A4 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709485B2 (en) 2002-10-29 2010-05-04 Glaxosmithkline Llc IL-8 receptor antagonists
US7893089B2 (en) 2006-04-21 2011-02-22 GlaxoSmithKline, LLC IL-8 receptor antagonists
US8097626B2 (en) 2006-04-21 2012-01-17 Glaxosmithkline Llc IL-8 receptor antagonists

Also Published As

Publication number Publication date
JP2003525856A (en) 2003-09-02
EP1107943A1 (en) 2001-06-20
EP1107943A4 (en) 2002-07-24
CA2341711A1 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
WO2008119793A1 (en) Process for the preparation of entacapone and intermediates thereof
JP3450389B2 (en) Method for producing L-5- (2-acetoxy-propionylamino) -2,4,6-triiodo-isophthalic dichloride
JP2003292476A (en) Method for producing diaminoresorcinol compound
JPH06329647A (en) Production of 2-(4-alkoxy-3-cyanophenyl)thiazole derivative and new production intermediate therefor
WO2000012461A1 (en) Process for making 2-amino-5-cyanophenol
US6037495A (en) Process for producing alkoxyiminoacetamide derivatives
US4665246A (en) Method of producing ethynyl aromatic compounds
EP1873145B1 (en) Method for producing nicotinic acid derivative or salt thereof
US5945565A (en) Process for the manufacture of acetonylbenzamides
EP1431278A1 (en) Process for producing (2-nitrophenyl)acetonitrile derivative and intermediate therefor
US5329041A (en) Trisubstituted benzoic acid intermediates
JP2004262863A (en) Method for producing orthobenzidine compound
Zezula et al. A novel divergent synthesis of ortho-hydroxy-e and-f oxide-bridged 5-phenylmorphans
EP0454871B1 (en) Alpha, beta-unsaturated ketone and ketoxime derivative
KR100368896B1 (en) A process for preparing 6-aminomethyl-5H-dibenz[b,e]azepine
US4594429A (en) Process for producing the 3-chloro-1-formyl-4-phenylpyrroles
US5969200A (en) Process for the manufacture of acetonylbenzamides
JP2003171359A (en) Method for producing (2-nitro-phenyl) acetonitrile derivative and synthetic intermediate thereof
KR19980018174A (en) Selective Nitriding Method of Phenolic Derivatives
JP4662649B2 (en) Novel phosphine compounds
JPH0586000A (en) Method for producing 2-amino-4-fluorobenzoic acid
WO2022256358A1 (en) Process for preparing medicaments
JPH0841005A (en) Production of 4-fluoroalkoxycynnamonitrile compound
CN120485299A (en) A method for preparing an intermediate
CN119100934A (en) A kind of preparation method of 2-amino-3-bromotrifluorotoluene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1999943937

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2341711

Country of ref document: CA

Ref country code: CA

Ref document number: 2341711

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09763740

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999943937

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999943937

Country of ref document: EP